Overview
This is a post-marketing observational clinical investigation conducted as part of the post-market clinical follow-up of ChitoCare® Medical, aimed to confirm safety and efficacy according to the requirements of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, for the following indications:
Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne
Spray - conditions after dermatosurgical procedures, dermatitis, acne
Eligibility
The inclusion criteria are fully according to indications:
- Gel - scars, conditions after dermatosurgical procedures, dermatitis, acne
- Spray - conditions after dermatosurgical procedures, dermatitis, acne
The criteria for exclusion are fully according to contraindications:
- Allergy to any of the ingredients of the product